PH13837A - Influenza vaccine containing purified neuraminidase antigen and method of using the same - Google Patents

Influenza vaccine containing purified neuraminidase antigen and method of using the same

Info

Publication number
PH13837A
PH13837A PH17976A PH17976A PH13837A PH 13837 A PH13837 A PH 13837A PH 17976 A PH17976 A PH 17976A PH 17976 A PH17976 A PH 17976A PH 13837 A PH13837 A PH 13837A
Authority
PH
Philippines
Prior art keywords
same
influenza vaccine
vaccine containing
containing purified
neuraminidase antigen
Prior art date
Application number
PH17976A
Other languages
English (en)
Inventor
E Kilbourne
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/541,512 external-priority patent/US4029763A/en
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Publication of PH13837A publication Critical patent/PH13837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PH17976A 1975-01-16 1976-01-15 Influenza vaccine containing purified neuraminidase antigen and method of using the same PH13837A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/541,512 US4029763A (en) 1974-08-05 1975-01-16 Influenza vaccine containing purified neuraminidase antigen and method of using the same

Publications (1)

Publication Number Publication Date
PH13837A true PH13837A (en) 1980-10-16

Family

ID=24159889

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17976A PH13837A (en) 1975-01-16 1976-01-15 Influenza vaccine containing purified neuraminidase antigen and method of using the same

Country Status (7)

Country Link
AU (1) AU507149B2 (fr)
BE (1) BE837603A (fr)
CA (1) CA1073355A (fr)
FR (1) FR2297635A1 (fr)
GB (1) GB1536475A (fr)
NL (1) NL7600443A (fr)
PH (1) PH13837A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins

Also Published As

Publication number Publication date
FR2297635B1 (fr) 1980-06-27
CA1073355A (fr) 1980-03-11
AU507149B2 (en) 1980-02-07
FR2297635A1 (fr) 1976-08-13
AU1016376A (en) 1977-07-14
NL7600443A (nl) 1976-07-20
BE837603A (fr) 1976-05-03
GB1536475A (en) 1978-12-20

Similar Documents

Publication Publication Date Title
IT1075017B (it) Procedimento per il trattamento di estratti antocianinici
IL47177A0 (en) Antipregnancy vaccine
JPS52114018A (en) Purification and isolation of hepatisis virus for producing vaccine
IT1069277B (it) Procedimento ed impianto per la depurazione di alogenosilani
AU504454B2 (en) Hepatitis b antigen and vaccine
AU1658276A (en) Preparation of tertiary aliphatic amines
IL51864A0 (en) Rabies vaccine and its preparation
FR2298529A1 (fr) Amines cycloaliphatiques
JPS51133414A (en) Production of vaccine against viral hepatisis
JPS5244230A (en) Detection of hepatisis antigen and antibody and hepatisis vaccine
IT1058978B (it) Processo per la preparazione di acetacetilarilamidi
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
AU1606576A (en) Rabies virus vaccine processes
JPS5239683A (en) Nnaryllnn*44piperidinyl*aryll acetoamide preparation method and medicinal uses
PH13199A (en) Methods and pharmaceutical preparation for the treatment of hypercholesterolaenia
CS191254B2 (en) Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza
IT1063583B (it) Processo per la preparazione di p alchilfenoli
AU507682B2 (en) Preparation of tertiary amines
PH13837A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
JPS5231825A (en) Identification of virus
IT1070568B (it) Processo per la preparazione di butendioldiacetato
IT1066183B (it) Procedimento per la preparazione di nerofumo di gas
JPS51142528A (en) Production of vaccine based on antigenic libosome fractionation
RO77284A (fr) Procede pour la preparation et la purification des resines epoxydes